In 2016 the PCC provided 28 funding awards to the scientific anti-doping community. This post shows the breakdown of awards as a product of funding mechanism. Center of Excellence (equipment grants) are considered regular grants as they are applied for during regular grant cycles.


Grants: 43%

Projects funded during the PCC’s three regular grant cycles accounted for 12 research projects in 2016, including:

Cycle 3

Application of Dried Blood Spots in the Detection of Insulin and Testosterone Ester. Dr. Nikolai Nordsborg, University of Copenhagen. (DE)

Exhaled Breath in Doping Controls: Method Expansion, Optimization, Detection Window Determination. Dr. Mario Thevis, German Sport University. (DE)

Characterization of low temperature catalytic combustion reactors for steroids in fast GC-C-IRMS. Dr Herbert Tobias, Dell Pediatric Institute. (US)

Cycle 2

Sensitive and Quick Detection of PEDs Using Microtoroid Optical Resonators. Dr. Judith Su, University of Arizona. (US)

Androgen Monitoring of Amateur and Young Athletes. Dr. Fred Schaufele, X-Cell Assay. (US)

Development of a Capillary-Electrophoresis Method for Detection of Recombinant Erythropoietins. Dr. Phillipe Desharnais, IRNS Sante. (CA)

Evaluating Erthroferrone as a New Marker of Erthropoesis Stimulators Abuse. Dr. Gaetano Cairo, University of Milan. (IT)

Cycle 1

Rapid Detection of Performance Enhancing Drugs Using Nanotechnology. Dr. Nico Voelcker, Monash University. (AU)

Real Time Screening for Novel Designer Drugs and Other Controlled Substances in Doping Control. Dr. James Harynuk, University of Alberta. (CA)

Rapid Detection of EPO Isoforms in Blood by Handheld Raman and Electrochemical Devices. Dr. Emad Kiriakous, Queensland University of Technology. (AU)

Purchase of Dried Blood Spot Automated Sampling Handler. SMRTL/UCLA (US)

Micro-Grants: 32%

Projects funded under the PCC’s Micro-Grant program, which supports projects addressing imminent challenges or gathering preliminary data for larger PCC funded research accounted for nine research projects in 2016, including:

Exhaled Breath as a Potential Alternative Matrix in Doping Controls: A Pilot Study. Dr. Mario Thevis, German Sport University. (DE)

Testosterone Codeine Interaction Study (Micro-Grant). Dr. Lena Ekstrom, Karolinksa Institutet. (SE)

Mildronate Pilot Excretion Study (Micro-Grant). Dr. Mario Thevis, German Sport University Cologne. (DE)

Reference materials of long-term metabolite of Oral-Turinabol. Dr. Maria Parr. Freie Universität Berlin. (DE)

Conversion of the Hematologic Passport Testing for Use with Dried Blood Spots. Dr. Daniel Eichner, SMRTL. (US)

Urine Steroid Profile in Testosterone-Treated Female-to-Male (F2M) Transgender Men (Micro-Grant). Dr. David Handelsmann, Anzac Institute. (AU)

Novel Low Temperature Catalytic Combustion Reactors for Fast GCC/IRMS (Micro-Grant). Dr Herbert Tobias, Dell Pediatric Institute (Research performed at Cornell University). (US)

DPS Card Manufacturing. Dr. Jack Henion, Q2 Solutions. (US)

Administration of Clomiphene: Short and Long Term Metabolism in an Anti-Doping Setting. Dr. Daniel Eichner, SMRTL. (US)

Working Groups: 21%

Working Group awards, which are provided to all members of scientific teams, accounted for six awards in 2016, including:

IGF-1 Working Group (5 awards). (US, DE, UK. )

Hematology Working Group. (US0

Fellowships: 4%

A PCC Fellowship was granted to one applicant in 2016: Liying Jiang, who is currently working under Dr. David Cowan at the Drug Control Center at King’s College London.